Suberoylanilide hydroxamic acid affects Î³H2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.

Blattmann, C; Oertel, S; Thiemann, M; Weber, K J; Schmezer, P; Zelezny, O; Lopez Perez, R; Kulozik, A E; Debus, J; Ehemann, V

Blattmann, C; Oertel, S; Thiemann, M; Weber, K J; Schmezer, P; Zelezny, O; Lopez Perez, R; Kulozik, A E; Debus, J; Ehemann, V.

Affiliation

Blattmann C; Department of Pediatric Oncology, Hematology, Immunology, and Pulmology, University Children's Hospital, Im Neuenheimer Feld 430, Heidelberg, Germany. audia.blattmann@med.uni-heidelberg.de

Strahlenther Onkol ; 188(2): 168-76, 2012 Feb.

Article in En | MEDLINE | ID: mdl-22249335

Subject(s)

Histones/biosynthesis; Hydroxamic Acids/administration & dosage; Osteosarcoma/pathology; Osteosarcoma/radiotherapy; Radiation Tolerance/drug effects; Teratoma/pathology; Teratoma/radiotherapy; Cell Line, Tumor; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Histone Deacetylase Inhibitors/administration & dosage; Humans; Radiation Dosage; Radiation-Sensitizing Agents/administration & dosage; Treatment Outcome; Vorinostat

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Radiation Tolerance / Teratoma / Histones / Osteosarcoma / Hydroxamic Acids Type of study: Guideline Limits: Humans Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google